Ahmed Gaffer Hegazi’s biography, net worth, fact, career, awards and life story

Intro Egyptian scientist
Is Scientist 
From Egypt 
Type Science 
Gender male
Birth 31 May 1948
Age: 72 years

Ahmed Hegazi (or Ahmed Gaffer Hegazi; احمد جعفر حجازى) (born May 31, 1948) is currently a Professor of Microbiology and Immunology in the department of Zoonotic Diseases, National Research Center, Egypt. Prof. Hegazi received his master’s degree in 1979, and his PhD in 1981. Hegazi’s research work has been focused lately on bee products and their therapeutic effects.
Hegazi Organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He has published 166 scientific papers and articles in national and international journals. He also served on the board of multiple national and international scientific journals.
Dr. Hegazi is also the president of the Egyptian Environmental Society for Uses and Production of Bee Products, secretary of the Egyptian Society of Apitherapy, secretary general of the African Federation of Apiculture Associations, and a member of the International Apitherapy Commission (APIMONDIA).

Awards

  • First Class Decoration of Excellence, Egypt, 1995
  • The Senior Scientist Prize of National Research Center, Cairo, Egypt, 1996
  • The National Scientific Prize In Biological Sciences, Egypt, 1990
  • The Scientific Prize of The National Research Center, Cairo, Egypt, 1989
  • The Second Best Research Paper Award, International Congress of Propolis, Bones Airs, Argentina, 2000
  • Main Speaker Award,10th Academic Conference, PRA and NAS (Nippon Apitherapy Soc.) Japan, 2006
  • 2 Bronze medals from The International Innovation Fair of the Middle East, Kuwait, 2007

Patents

  • Patent No. 8901 at 22/08/2006: A novel drug from natural products with new therapeutic modalities in treatment of psoriasis
  • Patent No. 1005 at 02/01/2006: A novel drug from natural resources for controlling Fascioliasis
  • Patent No. 270: at 01/06/2005: A novel drug from medicinal plants with antiatherosclerotic (hypocholesterolaemic), antioxidant and cardio protective properties.
  • Patent No. 272: at 01/06/2005: A novel drug from natural resources with antiatherosclerotic (hypocholesterolaemic), antioxidant and cardio protective properties.

Scientific Activities

Editor in the following International Journals:

  • Research Journal of Allergy, 2007
  • International Journal of Virology, 2007
  • Current Research In Tuberculosis, 2007
  • Research Journal of Veterinary Science, 2007
  • Research Journal of Microbiology, 2007
  • International Journal of Cancer Research, 2007
  • Research Journal of Medicinal plants, 2007

Referee in the following International Journals:

  • Journal of Planta Medica, 2005
  • Journal of Evidence Based Complementary and Alternative Medicine, 2006
  • International Journal of Radiation Biology, 2007
You May Also Like

Kevin McCall’s net worth, biography, fact, career, awards and life story

Kevin McCall net worth: Kevin McCall is an American singer-songwriter, producer, and rap artist who has a net worth of $1 million dollars. Kevin McCall was born in Watts, California, and began his professional music career, primarily as a writer and producer, in 2007. He is currently signed to RCA Records and Chris Brown Entertainment. Since 2010, he has written and/or produced multiple tracks for Chris Brown, including “Burnt”, “Shoes”, “Big Booty Judy”, “Work Wit It”, “Twitter (Follow Me)”, “Deuces”, “Ain’t Thinkin’ ‘Bout You”, “Make Love”, “Miss Breezy”, “You Want Me”, “Yesterday”, and “One Night Stand”. He also wrote and/or produced “Lighthouse” for Joe Jonas and “Christmas Eve” for Justin Bieber. He has released five mixtapes and three major singles. His track, “Strip”, performed with Chris Brown, reached #3 on the US R&B charts. His track, “Deuces”, was an R&B #1, and earned him a Grammy Award nomination for Best Rap/Song Collaboration in 2011.
Read More